Another day, another round of life sciences layoffs. This time, the spotlight falls on Bristol Myers Squibb, the New Jersey-based pharmaceutical giant. The company has announced a sweeping plan to shed 2,200 jobs and save $1.5 billion by 2025. This story has become eerily familiar in the biotech sector. Rising economic pressures have put companies […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
All-Cash Buyer Pays $444 per SQFT, Well Above the Silicon Valley R&D...
ByThe RegistrySeptember 29, 2026About a year after a CMBS lender took back 244 Jackson Street...
ByThe RegistrySeptember 29, 2026Walmart has finished a $150 million interior buildout of Moffett Green, the...
ByThe RegistrySeptember 29, 2026Waterford Property Co. aims to add up to 2,500 homes in Santa...
ByThe RegistrySeptember 29, 2026